Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
Quick Stats
Jul 14, 202649.3
AI Score
HOLD0.7
Volume Ratio
Aug 10, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
CAPR Stock Summary
Last updated Jul 14, 2026
CAPR is currently trading at $20.68, positioned below its 200-day moving average of $22.82, suggesting bearish momentum. The stock has a 52-week range of $4.3 to $40.37.
Technical Analysis: The 50-day moving average stands at $27.51, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.856, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.203, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CAPR at 49.3/100 with a HOLD recommendation.
CAPR (Capricor Therapeutics Inc) Indicators
Last updated Jul 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 28.856 |
| CMF (20) | -0.203 |
| ROC (10) | -13.109 |
| ADX (14) | 32.578 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.968 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -95.26 |
| MFI (14) | 13.051 |
CAPR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CAPR Price vs Max Options Open Interest
CAPR Max Change In Options Open Interest
CAPR Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily Out of Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily In the Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Most Active Options by Volume(near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Capricor Therapeutics Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CAPR Moving Averages Analysis
CAPR (Capricor Therapeutics Inc) Simple Moving Averages
Moving Averages are last updated Jul 14, 2026
| Days | MA |
|---|---|
| 10 | 22.26 |
| 20 | 25.04 |
| 30 | 25.58 |
| 50 | 27.51 |
| 100 | 29.28 |
| 200 | 22.82 |
CAPR Fundamental Analysis
| P/E (Forward) | 78.7402 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.2 billion |
| Earnings/Share ($) | -2.32 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.2222 |
| EPS Estimate Next Year ($) | -0.6422 |
| WallStreet Target Price ($) | 53.6 |
| Most Recent Quarter |
News Summary: WSJ reports that Trump has approved a plan to fire FDA Commissioner Dr. Marty Makary. Investors speculate on potential new FDA chief. $CAPR stock closes at $32+, with big investors buying. Discussions on potential outcomes for CAPR's agreement with NS Pharma and Medicare Part B model. Shorts set resistance around $31, but uncertainty remains. Potential for Capr to double projections with new agreements.
Updated 2026-05-08 16:00:01